{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:04:26Z","timestamp":1777914266384,"version":"3.51.4"},"reference-count":30,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Psychological Medicine"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Alcohol Dependence Syndrome (ADS) is a prevalent condition marked by difficulty controlling alcohol use, with significant global health impacts. Despite the effectiveness of anti-craving medications like Naltrexone, Acamprosate, Baclofen, Ondansetron, and Topiramate, these medications remain underutilized by healthcare providers. This study aims to assess the relationship between craving and relapse rates among individuals prescribed anti-craving medications and to explore the correlation between medication dosage and craving severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This was a prospective observational cohort study in which individuals prescribed anti-craving medications were monitored over three months. The study utilized the Penn Alcohol Craving Scale (PACS) to measure craving intensity and the Medication Adherence Rating Scale (MARS) to assess medication adherence. Alcohol use patterns were categorized into relapse, lapse, abstinence, and active use based on predefined operational definitions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Participants were between 30 and 50 years old and predominantly male. Severe dependence was observed in the majority of cases, and baclofen was prescribed to most participants. Pearson\u2019s correlation between Severity of Alcohol Dependence Questionnaire (SADQ-C) and PACS scores was\n                      <jats:italic>r<\/jats:italic>\n                      = 0.304 (\n                      <jats:italic>p<\/jats:italic>\n                      = .017), and MARS scores significantly predicted PACS scores (\n                      <jats:italic>R<\/jats:italic>\n                      = 0.757,\n                      <jats:italic>R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 0.573,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; .001). Most participants were in the action phase, with a significant proportion maintaining abstinence. However, relapse rates increased as the study progressed. Overall, adherence to anti-craving medications reduced cravings and facilitated abstinence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The research noted a significant reduction in craving in individuals receiving anti-craving medications. Nevertheless, no statistically significant correlation was identified between the dosage of Baclofen and PACS scores.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02537176251359425","type":"journal-article","created":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T04:24:13Z","timestamp":1755318253000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing Cravings Among Individuals with Alcohol Dependence Syndrome Prescribed with Anti-craving Medication: A Prospective Observational Study"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6794-4551","authenticated-orcid":false,"given":"Madiha","family":"Sultana","sequence":"first","affiliation":[{"name":"Dept. of Pharmacy Practice, College of Pharmaceutical Sciences, Dayananda Sagar University, Ramanagara, Karnataka, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushar","family":"Verma","sequence":"additional","affiliation":[{"name":"Dept. of Pharmacy Practice, College of Pharmaceutical Sciences, Dayananda Sagar University, Ramanagara, Karnataka, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8975-6976","authenticated-orcid":false,"given":"Anju","family":"Jose","sequence":"additional","affiliation":[{"name":"Dept. of Pharmacy Practice, College of Pharmaceutical Sciences, Dayananda Sagar University, Ramanagara, Karnataka, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4806-0697","authenticated-orcid":false,"family":"Gopal Das CM","sequence":"additional","affiliation":[{"name":"Dept. of Psychiatry, Dr. Chandramma Dayananda Sagar Institute of Medical Education and Research, Ramanagara, Karnataka, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3632-718X","authenticated-orcid":false,"family":"Neeraj Raj B","sequence":"additional","affiliation":[{"name":"Dept. of Psychiatry, Dr. Chandramma Dayananda Sagar Institute of Medical Education and Research, Ramanagara, Karnataka, India."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"key":"e_1_3_2_2_2","first-page":"e48419","article-title":"Assessing the behavioral and personality changes in alcohol dependence syndrome in Wardha, Central India","volume":"15","author":"Ray A","year":"2023","unstructured":"Ray A, , Ninave S, , Patil PS, . Assessing the behavioral and personality changes in alcohol dependence syndrome in Wardha, Central India. Cureus, 2023; 15: e48419.","journal-title":"Cureus"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_873_19"},{"key":"e_1_3_2_4_2","unstructured":"Poznyak V and Rekve D eds. Global status report on alcohol and health 2018. pp. 1\u2013450. www.who.int\/publications\/i\/item\/9789241565639 (2018 accessed November13 2024)."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2015.0584"},{"key":"e_1_3_2_6_2","first-page":"348","article-title":"Alcohol dependence, withdrawal, and relapse","volume":"31","author":"Becker HC","year":"2008","unstructured":"Becker HC. Alcohol dependence, withdrawal, and relapse. Alcohol Res Health, 2008; 31: 348\u2013361.","journal-title":"Alcohol Res Health"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/acer.12331"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.11406"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2006.47.2.167"},{"key":"e_1_3_2_10_2","first-page":"165","article-title":"What is craving? Models and implications for treatment","volume":"23","author":"Anton RF","year":"1999","unstructured":"Anton RF. What is craving? Models and implications for treatment. Alcohol Res Health, 1999; 23: 165\u2013173.","journal-title":"Alcohol Res Health"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.02.027"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/add.13974"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.4103\/psychiatry.IndianJPsychiatry_201_19"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/37.5.504"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04054.x"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.8.1423"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12028"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.4103\/0972-6748.196043"},{"key":"e_1_3_2_19_2","first-page":"75","volume-title":"The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines","author":"World Health Organization","year":"1992","unstructured":"World Health Organization. The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992, pp.75\u201378."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1979.tb02415.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1983.tb05502.x"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1999.tb04349.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(99)00130-9"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.4278\/0890-1171-12.1.38"},{"key":"e_1_3_2_25_2","volume-title":"Substance abuse: A comprehensive textbook","author":"Lowinson JH","year":"2005","unstructured":"Lowinson JH, ed. Substance abuse: A comprehensive textbook. Lippincott Williams & Wilkins, 2005."},{"key":"e_1_3_2_26_2","volume-title":"Alcohol\u2019s effects on health, research-based information on drinking and its impact","author":"Understanding binge drinking","year":"2004","unstructured":"Understanding binge drinking. Alcohol\u2019s effects on health, research-based information on drinking and its impact. Bethesda: The National Institute on Alcohol Abuse and Alcoholism (NIAAA), https:\/\/www.niaaa.nih.gov\/publications\/brochures-and-fact-sheets\/binge-drinking (2004, accessed May15, 2025)."},{"key":"e_1_3_2_27_2","unstructured":"FDA Cder. REVIA\u2192 (naltrexone hydrochloride tablets USP) 50 mg Opioid antagonist [Internet] https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/018932s017lbl.pdf (accessed May15 2025)."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(18)30010-0"},{"key":"e_1_3_2_29_2","first-page":"125","article-title":"High-risk behavior in patients with alcohol dependence","volume":"61","author":"Korlakunta A","year":"2019","unstructured":"Korlakunta A, and Reddy CMP. High-risk behavior in patients with alcohol dependence. Indian J Psychiatry, 2019; 61: 125\u2013130.","journal-title":"Indian J Psychiatry"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01555.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.08060852"}],"container-title":["Indian Journal of Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02537176251359425","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02537176251359425","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02537176251359425","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:46:30Z","timestamp":1777653990000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02537176251359425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":30,"alternative-id":["10.1177\/02537176251359425"],"URL":"https:\/\/doi.org\/10.1177\/02537176251359425","relation":{},"ISSN":["0253-7176","0975-1564"],"issn-type":[{"value":"0253-7176","type":"print"},{"value":"0975-1564","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"article-number":"02537176251359425"}}